Center for Fetal and Placental Research

Faculty Labs

Although prenatal diagnosis and fetal therapy continue to advance, high complication rates—particularly preterm birth and preterm prelabor rupture of membranes (PPROM)—remain a major challenge, and the Forde Lab addresses this through innovative translational research that integrates cellular-level studies of the amniotic sac, animal models of novel fetal therapies, and clinical outcomes data to better understand and ultimately mitigate the mechanisms driving these risks.

The Galganski Lab’s goal is to develop new ways to treat disease before birth, including anomalies such as congenital diaphragmatic hernia, myelomeningocele and twin to twin transfusion syndrome.

The Lim Lab pioneers innovation in prenatal diagnosis and in utero therapy, integrating advanced risk stratification, biomarker discovery, translational operative models, and longitudinal multidisciplinary care to understand fetal disease, intervene before birth, and improve short‑ and long‑term outcomes.